Research | Projects | Grants | Publications | Team | Join Us | Contact

The MIND Lab at the University of North Texas develops objective, AI-driven tools that help clinicians make better decisions for patients with neurological and psychiatric disorders. Our research combines EEG signal processing, deep learning, and explainable AI to translate brain signals into actionable clinical insights.

 

5

Neurological & Psychiatric Disorders Studied
2

Countries — USA and Canada
2

Active IRB-Approved Protocols
460+

Target Patients Across Both Studies

Research Areas

EEG-based machine learning for clinical translation.

EEG-Based Depression Therapy Prediction
Using resting-state EEG biomarkers to predict which depression therapy — SSRIs (escitalopram), rTMS, or ketamine — will work best for each patient before treatment begins.
ADHD Severity Stratification
Stratifying ADHD severity on a continuous spectrum using EEG biomarkers to enable personalized treatment selection based on individual patient profiles
Alzheimer's and FTD Classification
EEG-based classifiers for Alzheimer's and FTD using hybrid signal processing methods — time-frequency analysis, connectivity measures, and novel feature extraction — with interpretable AI for clinical translation.
Explainable AI for Clinical Decision Support
Applying XAI methods including Grad-CAM++, Integrated Gradients, and SHAP to make deep learning predictions interpretable and actionable for clinicians.
Seizure Prediction and Classification

Automated seizure prediction and classification from EEG using CNNs combining multi-method feature engineering — time-frequency representations, connectivity measures, and novel signal processing frameworks.

Mother Tree Optimization (MTO)

A nature-inspired optimization algorithm developed by Dr. Korani, applied to feature selection, data clustering, constraint satisfaction, and medical diagnosis.

Current Projects

Our lab is currently conducting two IRB-approved studies with clinical partners in the Dallas–Fort Worth area.

EEG-Based Prediction of Depression Therapy Outcome

Developing and validating objective EEG biomarkers to predict which depression therapy — SSRIs (escitalopram), rTMS, or ketamine — will produce clinical remission for each patient before treatment initiation. Two-phase approach: secondary analysis of CAN-BIND DR008 longitudinal cohort (~309 MDD patients, 5 timepoints) for initial biomarker discovery, followed by prospective validation in 150 treatment-naive MDD patients at Center for Integrative Psychiatry under IRB-26-91.

IRB Approved · Active

EEG-Based Prediction of Treatment Outcomes for Depression and ADHD

Prospective EEG data collection from patients with MDD and ADHD at the Center for Integrative Psychiatry under IRB-26-91 (Full Board Approval, May 2026), in collaboration with Co-Investigator Dr. Tahir Khwaja, Medical Director and triple board-certified psychiatrist.

IRB Approved · In Progress

Time-Frequency EEG Representations for Alzheimer's and FTD Classification
Comparing DWT, FBSE, and WVD time-frequency representations for CNN-based discrimination of Alzheimer's disease from frontotemporal dementia and cognitively normal controls under strict subject-disjoint validation.

In Progress
EEG-Based Seizure Classification
Developing automated CNN-based seizure detection and classification systems using novel time-frequency feature extraction frameworks. The goal is to identify seizure types from scalp EEG with high patient-level accuracy under subject-independent validation.

In Progress
EEG-Based Seizure Prediction
Extending seizure classification toward pre-ictal state detection — predicting seizure onset before it occurs using resting-state and ictal EEG biomarkers. This work will lay the groundwork for a future grant targeting real-time seizure warning systems.

Planned

Grants & Funding

Our research is supported by competitive federal funding from the National Institutes of Health.

Grant 1 (NIH R21): EEG-Based Neurophysiological Biomarkers for Predicting Depression Therapy Outcome

  • Two-phase validation study
  • Total funding: $389,868 (April 2027 – March 2029)
  • Proposal ID: GFP0003528
  • Under Review

Grant 2 (NIH R03): EEG-Based Objective Biomarkers for ADHD Classification and Treatment Stratification

  • Small research grant focused on correcting patient-level data leakage issues
  • Submitted: October 2026 (PA-25-302)
  • Funding: Up to $100,000 (2-year project)
  • Submitted

Publications & Resources

Peer-reviewed research advancing EEG-based machine learning for clinical translation.

Depression Therapy Prediction

Alzheimer’s and FTD Classification

Seizure Detection and Classification

Other EEG Applications

  • Detecting Mental Arithmetic Activities Using the Determinant Feature of EEG Signals in the Dynamic Graph Mode Decomposition Domain. Mathematical and Computational Biology, 2026 (accepted).

Mother Tree Optimization (MTO)

Lab Members

A collaborative team of researchers working at the intersection of neuroscience, data science, and clinical medicine.

Wael Korani, Ph.D.
Wael Korani, Ph.D.
Principal Investigator
Assistant Professor of Data Science
Dr. Korani leads the MIND Lab at the University of North Texas. His research focuses on EEG-based machine learning for neurological and psychiatric disorders, with expertise in time-frequency analysis, explainable AI, and clinical decision support systems. He has published peer-reviewed studies on EEG-based prediction of depression therapy outcomes, seizure detection, Alzheimer's classification, and brain tumor detection.

PhD Students

Salleh Sonko
Salleh Sonko
PhD Student
EEG-based Alzheimer's disease classification
Eunice Amoje
Eunice Amoje
PhD Student
EEG-based prediction of depression therapy outcomes
Muhammad Bilal
Muhammad Bilal
PhD Student
EEG-based depression therapy outcome prediction using fusion methods
Chakradhar Sai
Chakradhar Sai
PhD Student
ADHD classification and discrimination from healthy controls using EEG

Master's Students

Md Fahimul Kabir Chowdhury
Md Fahimul Kabir Chowdhury
Master's Student
EEG-based time-frequency fusion for depression therapy outcome prediction
Shyam Sundar Domakonda
Shyam Sundar Domakonda
Master's Student
Brain tumor detection and depression therapy outcome prediction

Clinical and Research Collaborators

  • Dr. Tahir Khwaja, M.D.Medical Director, Center for Integrative Psychiatry · Coppell and North Dallas, TX
  • Dr. Gahangir Hossain, Ph.D.University of North Texas · Department of Data Science
  • Dr. Reza Rostami & Dr. Reza KazemiTehran University of Medical Sciences, Iran

Join the MIND Lab

We welcome motivated students and researchers passionate about applying machine learning to advance mental health care.

PhD Students
Funded positions expected pending NIH grant approval. Self-funded and fellowship students are welcome to apply now. Strong background in signal processing, machine learning, or neuroscience preferred.
Master's Students
Research opportunities available for master's students interested in EEG analysis, deep learning, or clinical AI. Prior programming experience in Python required.
Undergraduate Researchers
Motivated undergraduates are encouraged to reach out about research experience opportunities in our lab. Great preparation for graduate school.
Clinical Collaborators
We actively seek partnerships with psychiatrists and neurologists interested in translational EEG research. Contact Dr. Korani to discuss collaboration.

Contact

Principal Investigator
Dr. Wael Korani, Ph.D.
Assistant Professor
Department of Data Science
University of North Texas
Address
1155 Union Circle
Denton, TX 76203
Discovery Park
Phone